North Carolina Governor Josh Stein announced Bracco, a company specializing in diagnostic imaging, will invest $230 million to open its first U.S. location to manufacture contrast media, a decision that's expected to create 200 jobs.
Founded in 1927, Bracco Imaging is a multinational life sciences company and a manufacturer of imaging diagnostic productions, contrast agents, medical devices and related solutions for health care providers. Bracco Imaging has headquarters in Milan, Italy, and production facilities in Europe, Asia, and Canada. The new sterile manufacturing plant will support the demand for injectable contrast media, resulting in shorter delivery times and lower transportation costs.
“For almost 100 years, Bracco has been guided by one purpose: improving people’s lives. The United States is our largest market and home to many of the patients we serve,” said Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging. “Producing injectable contrast media here in Sanford brings our supply closer to American hospitals and patients and makes it even more resilient. We chose North Carolina for its talent and life sciences ecosystem. As a family-owned company, we invest for the long term, and we look forward to growing with the Sanford community for decades to come.”
New positions include manufacturing, engineering, and technical roles, along with support operations, quality, warehousing and administrative positions.
